David Moss | Chief Financial Officer |
RJ Tesi | Chief Executive Officer & Chief Medical Officer |
Joel Beatty | Baird |
Greetings, and welcome to the INmune Bio Second Quarter 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. A transcript will follow within 24 hours of this conference call.
At this time, it is my pleasure to introduce to you Mr. David Moss, CFO of INmune Bio.